Immunarray vs Kanso Diagnostics

Immunarray vs Kanso Diagnostics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunarray is on 39/100 and Kanso Diagnostics on 53/100.

Immunarray logo
ImmunarrayImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.
Try Immunarray
Kanso Diagnostics logo
Kanso DiagnosticsDevelops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
Try Kanso Diagnostics

Where each one leads

Immunarray

  • domain rating: 18/100 against 1/100
  • funding raised: $10.0M against $1.8M

Kanso Diagnostics

  • our overall score: 53/100 against 39/100

At a glance

MeasureImmunarrayKanso Diagnostics
What it isImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
CategoryHealthcare, Blood, Diagnostics, ImmunologyHealthcare, Diagnostics, Genetics, Pathology
Sells toBusiness modelB2BB2B
OfferingSoftwarePlatform
Founded20062021
HeadquartersRichmond, United StatesOr Yehuda, Israel
StatusInactiveActive

Size, funding and growth

MeasureImmunarrayKanso Diagnostics
EmployeesNot published7
Headcount growthLast 12 monthsNot published+22.1%
Total funding$10.0M$1.8M
Latest roundSeries ASeed
LinkedIn followersNot published778

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunarrayKanso Diagnostics
StartupHub scoreOur 0-100 rating39/10053/100
Traction35/10040/100
Team30/10070/100
Community13/1008/100
Search visibility5/10039/100
Quality45/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (28/100)F (28/100)
Domain ratingLink authority, 0-10018/1001/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunarrayKanso Diagnostics
HostingNot detectedNetlify
CDNNot detectedNetlify

Immunarray vs Kanso Diagnostics: common questions

Which is better, Immunarray or Kanso Diagnostics?

On our 0-100 score Kanso Diagnostics rates higher (53/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do Immunarray and Kanso Diagnostics compare on the numbers?

Immunarray leads on domain rating (18/100 against 1/100), funding raised ($10.0M against $1.8M). Kanso Diagnostics leads on our overall score (53/100 against 39/100).

Read the full Immunarray review and pricing or the Kanso Diagnostics review and pricing. You can also browse other Immunarray alternatives we track.